scorecardresearch
Friday, September 27, 2024
Support Our Journalism
HomeHealthAbout 18-19 vaccine candidates against Covid-19 in pipeline, says Harsh Vardhan

About 18-19 vaccine candidates against Covid-19 in pipeline, says Harsh Vardhan

Health Minister Harsh Vardhan says Covid vaccines in the public domain are safe and effective, adding that in the next 2-3 weeks, vaccinations will begin for people above 50.

Follow Us :
Text Size:

New Delhi: About 18-19 vaccine candidates against COVID-19 are in the pipeline and in different clinical trial stages, Health Minister Harsh Vardhan said on Monday.

Addressing the media, Vardhan said that in the next 2-3 weeks, vaccinations against COVID-19 will be started for people above 50 years of age.

“About 18-20 vaccine candidates against COVID-19 are in the pipeline and are in preclinical, clinical and advanced stages,” Vardhan said.

He further said that India will be supplying vaccines to 20-25 other countries.

Dispelling rumours surrounding the vaccines, Vardhan said the vaccines in the public domain are safe and effective.

He said no new cases of COVID-19 have been reported in 188 districts of the country in the last 7 days, while no new cases have been reported in 21 districts in 21 days.

Vardhan further urged people to keep following COVID appropriate behaviour.

“It is crucial that people continue to follow COVID appropriate behaviour which I call social vaccine, along with real vaccines,” he said.

India has approved two vaccines — Covaxin developed by Bharat Biotech and Covishield from the Oxford/AstraZeneca stable being manufactured by the Serum Institute of India — for emergency use in the country.


Also read: Chile has ordered enough doses to fully vaccinate its population against Covid twice


 

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular